Daily non-political popular news in brief.

Radiation seeds effectively cure prostate cancer in young men

10-29-2007 · EurekAlert!

Radiation seed implants are just as effective at curing prostate cancer in younger men (aged 60 and younger) as they are in older men, according to a study presented at a scientific session on Oct. 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

Keywords: radiation, seeds, effectively, cure, prostate, cancer, young, men, seed

« Previous | Next »

Similar news on "Radiation seeds effectively cure prostate cancer in young men":

Prostate cancer patients see high survival rates with seed implants
01-31-2007 · EurekAlert!
More than 90 percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis, according to a study released in the February 1 issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of ASTRO.
Similar news · Read more »
Radiation therapy combo cures prostate cancer long-term
01-04-2007 · EurekAlert!
Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.
Similar news · Read more »
Prostate brachytherapy causes fewer side effects than surgery
02-28-2007 · EurekAlert!
Men with prostate cancer have a slightly better long-term side effects profile with radiation seed implants than they do with surgery, according to a study released today in the International Journal for Radiation Oncology*Biology*Physics, the official journal of Astro.
Similar news · Read more »
Radiation seed implant decreases risk of death over watchful waiting
10-31-2007 · EurekAlert!
Prostate cancer patients cut their risk of dying of the disease in half when they receive radiation seed implants to treat their cancer, compared to those who don't receive active treatment, within six months from being diagnosed with localized prostate cancer, according to a study presented Oct. 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Similar news · Read more »
Inaugural issue of American Journal of Men's Health
03-09-2007 · EurekAlert!
Testicular cancer is the most common malignancy among 15-35 year-old young men. Men over 65 tend to get prostate cancer, the second leading cause of cancer death among American men. Researchers and physicians need to get as much information on these serious killers as possible so that men can be better informed; which is why the American Journal of Men's Health by SAGE, has published this research in its first issue debuting this month.
Similar news · Read more »
Prostate cancer: Watchful wait or vaccinate?
02-01-2008 · EurekAlert!
Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease. In the Feb. 1 issue of Cancer Research, they suggest the same strategy might work for men with rising levels of PSA, a potential diagnostic indicator of prostate cancer
Similar news · Read more »
Study first: Over-expression of Cox-2 can predict prostate cancer outcome
11-08-2006 · EurekAlert!
Researchers say an over-expression of COX-2 in men with prostate cancer is associated with an increase in PSA after radiation treatment and the spread of the cancer outside of the prostate. That is the result of the first study linking COX-2 with prostate cancer radiation treatment outcomes.
Similar news · Read more »
Jefferson radiation oncologists use real-time system to plant 'seeds' against cancer
09-21-2007 · EurekAlert!
Radiation oncologists and urologists at the Kimmel Cancer Center at Jefferson have begun using a real-time system to implant radiation-emitting seeds in prostate cancer patients. While the system is only being used for imaging and planning so far, it ultimately will help in placing the seeds. The team hopes that the technology will make a good system even better, adding scientific precision to a treatment that currently relies mainly on physician experience and skill.
Similar news · Read more »
IMRT versus 3D CRT for prostate cancer, new long-term data assesses side effects
11-05-2006 · EurekAlert!
New research findings show men have fewer long-term gastrointestinal side effects with intensity-modulated radiation therapy (IMRT) than with three-dimensional conformal radiation therapy (3D CRT) for prostate cancer treatment, despite the higher doses of radiation used in the IMRT group. These and other data, including long-term genitourinary side effects, were presented today.
Similar news · Read more »
Just 4 months of hormone therapy can delay prostate cancer growth by up to 8 years
01-02-2008 · EurekAlert!
Researchers report that just four months of hormonal therapy before and with standard external beam radiation therapy slowed cancer growth by as much as eight years -- especially the development of bone metastases -- and increased survival in older men with potentially aggressive prostate cancer. This "neoadjuvant" hormonal therapy may allow men most at risk of developing bone metastases avoid long-term hormonal therapy later on.
Similar news · Read more »